IDegLira Versus Insulin Glargine U100: A Long-term Cost-effectiveness Analysis in the US Setting.

Barnaby HuntMichelle MocarskiWilliam J ValentineJakob Langer

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)

Novo Nordisk A/S and Novo Nordisk Inc.

Keyphrases